We use immunofluorescent co-staining with antibodies against IL-6 and Vimentin, a marker for cardiac fibroblasts on heart cross-sections from WT or Cad-11−/− mice with or without TAC respectively. The gene discussed is VIM; the disease is persistent truncus arteriosus.